Functional studies of cholinergic activity in normal and Alzheimer disease states by imaging technique

被引：14

作者：

Nordberg, A ^{[1
]}

机构：

[1] Huddinge Univ Hosp, Karolinska Inst, Neurotec Dept, Div Mol Neuropharmacol, S-14186 Huddinge, Sweden

来源：

ACETYLCHOLINE IN THE CEREBRAL CORTEX | 2004年 / 145卷

关键词：

D O I：

10.1016/S0079-6123(03)45021-8

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：301 / 309

页数：9

共 62 条

[51] Declining brain activity in cognitively normal apolipoprotein E ε4 heterozygotes:: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease [J].

Reiman, EM ;

Caselli, RJ ;

Chen, KW ;

Alexander, GE ;

Bandy, D ;

Frost, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (06) :3334-3339

[52] A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease [J].

Rogers, SL ;

Farlow, MR ;

Doody, RS ;

Mohs, R ;

Friedhoff, LT ;

Albala, B ;

Baumel, B ;

Booker, G ;

Dexter, J ;

Farmer, M ;

Feighner, JP ;

Ferris, S ;

Gordon, B ;

Gorman, DG ;

Hanna, G ;

Harrell, LE ;

Hubbard, R ;

Kennedy, J ;

McCarthy, J ;

Scharre, DW ;

Schaerf, F ;

Schneider, L ;

Seltzer, B ;

Siegal, A ;

Stark, SR ;

Strauss, A ;

Walshe, TM .

NEUROLOGY, 1998, 50 (01) :136-145

[53] Cognitive impairment and the cholinergic hypothesis: A very different take on recent data [J].

Sarter, M ;

Bruno, JP .

ANNALS OF NEUROLOGY, 2002, 52 (03) :384-385

[54] Effect of donepezil on brain acetylcholinesterase activity in patients with AD measured by PET [J].

Shinotoh, H ;

Aotsuka, A ;

Fukushi, K ;

Nagatsuka, S ;

Tanaka, N ;

Ota, T ;

Tanada, S ;

Irie, T .

NEUROLOGY, 2001, 56 (03) :408-410

[55] Early detection of Alzheimer's disease by combining apolipoprotein E and neuroimaging [J].

Small, GW ;

Komo, S ;

LaRue, A ;

Saxena, S ;

Phelps, ME ;

Mazziotta, JC ;

Saunders, AM ;

Haines, JL ;

PericakVance, MA ;

Roses, AD .

APOLIPOPROTEIN E GENOTYPING IN ALZHEIMER'S DISEASE, 1996, 802 :70-78

[56] Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease [J].

Small, GW ;

Ercoli, LM ;

Silverman, DHS ;

Huang, SC ;

Komo, S ;

Bookheimer, SY ;

Lavretsky, H ;

Miller, K ;

Siddarth, P ;

Rasgon, NL ;

Mazziotta, JC ;

Saxena, S ;

Wu, HM ;

Mega, MS ;

Cummings, JL ;

Saunders, AM ;

Pericak-Vance, MA ;

Roses, AD ;

Barrio, JR ;

Phelps, ME .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (11) :6037-6042

[57] Radiolabeled cholinesterase substrates:: In vitro methods for determining structure-activity relationships and identification of a positron emission tomography radiopharmaceutical for in vivo measurement of butyrylcholinesterase activity [J].

Snyder, SE ;

Gunupudi, N ;

Sherman, PS ;

Butch, ER ;

Skaddan, MB ;

Kilbourn, MR ;

Koeppe, RA ;

Kuhl, DE .

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2001, 21 (02) :132-143

[58] Functional MRI detection of pharmacologically induced memory impairment [J].

Sperling, R ;

Greve, D ;

Dale, A ;

Killiany, R ;

Holmes, J ;

Rosas, HD ;

Cocchiarella, A ;

Firth, P ;

Rosen, B ;

Lake, S ;

Lang, N ;

Routledge, C ;

Albert, M .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (01) :455-460

[59] Cerebral glucose metabolism, cerebrospinal fluid-β-amyloid1-42 (CSF-Aβ42), tau and apolipoprotein E genotype in long-term rivastigmine and tacrine treated Alzheimer disease (AD) patients [J].

Stefanova, E ;

Blennow, K ;

Almkvist, O ;

Hellström-Lindahl, E ;

Nordberg, A .

NEUROSCIENCE LETTERS, 2003, 338 (02) :159-163

[60] Upregulation of neuronal nicotinic receptor subunits α4, β2, and α7 in transgenic mice overexpressing human acetylcholinesterase [J].

Svedberg, MM ;

Svensson, AL ;

Johnson, M ;

Lee, M ;

Cohen, O ;

Court, J ;

Soreq, H ;

Perry, E ;

Nordberg, A .

JOURNAL OF MOLECULAR NEUROSCIENCE, 2002, 18 (03) :211-222

← 1 2 3 4 5 6 7 →